Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

Explore off times in advanced Parkinson's disease, understand symptoms, communicate with your doctor, and consider treatment strategies and lifestyle adjustments.

Steven Haahr, a certified personal trainer, explains that vibration plates are tied to a health concept called “whole body vibration,” in which a person stands on “platforms that oscillate, or shake, ...

Parkinson's disease (PD) is an age-related, progressive, neurodegenerative condition, caused by loss of dopamine-producing neurons. To overcome the shortcomings of conventional levodopa-based ...

Those with the sleep condition were more likely to develop Parkinson’s disease. But one treatment was found to help. By Caroline Hopkins Legaspi In a study published Monday in JAMA Neurology, ...

Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement pill called levodopa. It transformed the lives of millions of people.

Re “Sue Goldie Has Parkinson’s Disease” (front page, Oct. 14): I was diagnosed with Parkinson’s when I was 75, in November 2021. I understand exactly what Sue Goldie is going through. It’s not just ...

Bayer AG’s BAYRY wholly owned, independently operated subsidiary BlueRock Therapeutics LP announced positive 36-month data from an early-stage study of bemdaneprocel, an investigational cell therapy ...

Cell and gene therapies account for 20% of pipeline Parkinson's therapy bemdaneprocel in Phase 3 trial Pharma success urgently needed, says fund manager FRANKFURT, Sept 25 (Reuters) - Bayer's ...

MeiraGTx is a clinical-stage gene therapy biotech with end-to-end GMP. Its late-stage assets include AAV-AIPL1, AAV-AQP1, and Bota-Vec. AAV-AQP1 is in pivotal Phase 2 trials under the FDA’s RMAT ...

An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...